QQ客服 官方微博 反馈留言

	Aleglitazar, a Balanced Dual PPAR alpha and -gamma Agonist, Protects the Heart Against Ischemia-Reperfusion Injury
	Qian, Jinqiao; Chen, Hongmei; Birnbaum, Yochai; Nanhwan, Manjyot K.; Bajaj, Mandeep; Ye, Yumei
刊名	CARDIOVASCULAR DRUGS AND THERAPY
	2016
卷号	30期号:2
关键词	Aleglitazar Diabetes mellitus Hypoxia-reoxygenation injury Infarct size Ischemia-reperfusion Cardioprotection PPAR alpha, PPAR gamma
ISSN号	0920-3206
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3428910
专题	昆明医科大学
推荐引用方式 GB/T 7714	Qian, Jinqiao,Chen, Hongmei,Birnbaum, Yochai,et al. Aleglitazar, a Balanced Dual PPAR alpha and -gamma Agonist, Protects the Heart Against Ischemia-Reperfusion Injury[J]. CARDIOVASCULAR DRUGS AND THERAPY,2016,30(2).
APA	Qian, Jinqiao,Chen, Hongmei,Birnbaum, Yochai,Nanhwan, Manjyot K.,Bajaj, Mandeep,&Ye, Yumei.(2016).Aleglitazar, a Balanced Dual PPAR alpha and -gamma Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.CARDIOVASCULAR DRUGS AND THERAPY,30(2).
MLA	Qian, Jinqiao,et al."Aleglitazar, a Balanced Dual PPAR alpha and -gamma Agonist, Protects the Heart Against Ischemia-Reperfusion Injury".CARDIOVASCULAR DRUGS AND THERAPY 30.2(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。